silicon-modified indomethacin (Silamed)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namesilicon-modified indomethacin (Silamed)
Drug Alias Namesilicon-modified indometacin (Silamed)SilexsynSiM-100RND-100
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-2
Therapy Area/IndicationsAlzheimer DiseaseArthritisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSilamed Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSilamed Inc
Active IndicationsN/A
Inactive IndicationsAlzheimer DiseaseArthritisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A